These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 16491070)

  • 1. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
    Baylin SB; Ohm JE
    Nat Rev Cancer; 2006 Feb; 6(2):107-16. PubMed ID: 16491070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic changes in cancer and preneoplasia.
    Herman JG
    Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant gene silencing in tumor progression: implications for control of cancer.
    Baylin SB; Chen WY
    Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic drivers and genetic passengers on the road to cancer.
    Sawan C; Vaissière T; Murr R; Herceg Z
    Mutat Res; 2008 Jul; 642(1-2):1-13. PubMed ID: 18471836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer.
    Belinsky SA
    Carcinogenesis; 2005 Sep; 26(9):1481-7. PubMed ID: 15661809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes in virus-associated human cancers.
    Li HP; Leu YW; Chang YS
    Cell Res; 2005 Apr; 15(4):262-71. PubMed ID: 15857581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis.
    Balch C; Nephew KP; Huang TH; Bapat SA
    Bioessays; 2007 Sep; 29(9):842-5. PubMed ID: 17688287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fundamental role of epigenetic events in cancer.
    Jones PA; Baylin SB
    Nat Rev Genet; 2002 Jun; 3(6):415-28. PubMed ID: 12042769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic changes in cancer as potential targets for prophylaxis and maintenance therapy.
    Grønbaek K; Treppendahl M; Asmar F; Guldberg P
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):389-96. PubMed ID: 18947362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.